Kyverna Therapeutics, Inc.

KYTX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
49
SEC Filings

Business Summary

1 Item 1A. Risk Factors 44 Item 1B. Unresolved Staff Comments 119 Item 1C. Cybersecurity 119 Item 2. Properties 120 Item 3. Legal Proceedings 120 Item 4. Mine Safety Disclosures 121 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 122 Item 6. [Reserved] 123 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 124 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 13...

Next Earnings

Q2 FY2026 — expected 2026-09-18

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionKYTXdiscussed_in_filing Cybersecurity
topic_mentionKYTXdiscussed_in_filing Cybersecurity
topic_mentionKYTXdiscussed_in_filing Cybersecurity
topic_mentionKYTXdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001193125-26-126242EDGAR130K words
2025-03-272024-12-310000950170-25-046074EDGAR—
2024-03-262023-12-310000950170-24-036481EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-277584EDGAR80K words
2025-08-122025-06-300000950170-25-107321EDGAR—
2025-05-132025-03-310000950170-25-070325EDGAR—
2024-11-132024-09-300000950170-24-126366EDGAR—
2024-08-122024-06-300000950170-24-095462EDGAR—
2024-05-142024-03-310000950170-24-059628EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-260001193125-26-126216EDGAR3K words
2026-02-240001193125-26-065320EDGAR—
2026-02-030001193125-26-034464EDGAR—
2026-01-120001193125-26-009810EDGAR—
2025-12-180001213900-25-123033EDGAR—
2025-12-150001193125-25-318469EDGAR—
2025-12-150001193125-25-318377EDGAR—
2025-11-120001193125-25-277569EDGAR—
2025-11-030001193125-25-261719EDGAR—
2025-10-290001193125-25-254698EDGAR—

49 total filings indexed. 30 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001994702
TickerKYTX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 90c1bfa55ceeaa767f3e7a69ba0233dd98c4152864ee63c6d0cd022cb8132fd8
parent: 1110a07a18a56060f9718617ab813d7cde48fae7ebb911b9a03829752ede59ba
content hash: 96d437bd96884ab2ec0ba856423ce8a686afe1e8cb406d3053d2f8aca6f649da
signed: 2026-04-13T04:45:57.651Z
sources: 9 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf